Transcat Inc (TRNS) Stock AnalysisTRNSTranscat Inc

Transcat, Inc. is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. It is focused on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceuticals, biotechnology, medical devices, as well as aerospace and defense, and energy and utilities. It provides periodic onsite services, mobile calibration services, pickup and delivery, and in-house services at Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. Its segments include Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. The Distribution segment sells and rents national and proprietary branded instruments to customers globally. It operates in the Industrials sector (INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & EL industry).

Transcat Inc is currently a hold. The stock is priced at $86.23, which is close to the analyst target of $95, indicating limited upside potential in the near term. Additionally, the RSI is at 35.11, suggesting the stock is nearing oversold territory, but the recent 5-day change is down by 4.60%, indicating short-term weakness. The company reported a strong Q1 with a 22% revenue growth year-over-year, but the downgrade from Outperform to Market Perform suggests that analysts believe the stock is fully valued at this time.

2 analysts cover TRNS: 2 rate it Buy, 0 Hold and 0 Sell. The average price target is 100.00.